1. Steroids and Walden Inversion. Part XLVIII. The solvolysis of some 3-epimeric 4,4-dimethylsteroid toluene-p-sulphonates (C.W. Shoppee and G.A.R. Johnston, J. Chem. Soc., 1961, 3261-3271)
2. Constituents of the bark of Balanops australiana F. Muell. (C.W.Shoppee, M.E.H. Howden and G.A.R. Johnston, J. Chem. Soc., 1962,489-501)
3. Steroids and Walden Inversion. Part L. Comparative studies of alpha,beta- and alpha,alpha'-dibromoketones derived from friedelin and from 5-alpha-cholestan- 6-one (C.W. Shoppee and G.A.R. Johnston, J.Chem. Soc., 1246-1254)
4. Steroids and Walden Inversion. Part LI. The solvolysis of 4,4-dimethylcholest-5- en-3-alpha-yl toluene-p-sulphonate (C.W. Shoppee and G.A.R. Johnston, J. Chem. Soc., 1962, 2684-2691)
5. Steroids. Part XVI. The bromination of some 3-keto-steroids methylated in ring A (C.W. Shoppee, G.A.R. Johnston and R.E. Lack, J. Chem. Soc., 1962, 3604-3610)
6. Aliphatic monohydroxy-monocarboxylic acids and related compounds. Chapter 14 in Volume Id of Rodd's Chemistry of Carbon Compounds edited by S. Coffey, Elsevier, Amsterdam, 1965, pages 80-141 (D.St.C. Black, G.M. Blackburn and G.A.R. Johnston)
7. Aldehydic and ketonic monocarboxylic acids and related compounds. Chapter 17 in Volume Id of Rodd's Chemistry of Carbon Compounds edited by S. Coffey, Elsevier, Amsterdam, 1965, pages 214-274 (D.St.C. Black, G.M. Blackburn and G.A.R. Johnston)
8. Glycine and spinal inhibition (D.R. Curtis, L. Hösli, G.A.R. Johnston and I.H. Johnston, Brain Res., 1967, 5, 112-114)
9. Acetyl migration in derivatives of 3-beta-D-xylosyluracil (G.A.R. Johnston, Tetrahedron Letters, 1967, 2679-2683)
10. The inhibition of spinal neurones by glycine (D.R. Curtis, L. Hösli and G.A.R. Johnston, Nature, 1967, 215, 1502-1503)
11. Acylation of tRNA - studies on the acetylation of simple nucleosides (G.A.R. Johnston, Biochim. Biophys. Acta, 1967, 145, 831-833
12. Oxalyl-coenzyme A synthetase and the neurotoxin beta-N-oxalyl-L-alpha,beta-diaminopropionate (G.A.R. Johnston and H.J. Lloyd, Aust. J. Biol. Sci., 1967, 20, 1241-1244)
13. Approaches to the preparation of 3'-deoxynucleosides (G.A.R. Johnston, Aust. J. Chem., 1968, 21, 513-519)
14. Liquid cation exchange extraction of cholinomimetic activity from brain (G.A.R. Johnston, H.J. Lloyd and N. Stone, J. Neurochem., 1968, 15, 361-365)
15. The hyperpolarization of spinal motoneurones by glycine and related amino acids (D.R. Curtis, L. Hösli and G.A.R. Johnston, Exp. Brain Res., 1968, 5, 235-258)
16. A pharmacological study of the depression of spinal neurones by glycine and related amino acids (D.R. Curtis, L. Hösli and G.A.R. Johnston, Exp. Brain Res., 1968, 6, 1-18)
17. The intraspinal distribution of some depressant amino acids (G.A.R. Johnston, J. Neurochem., 1968, 15, 1013-1017)
18. The identification and estimation of choline derivatives by mass spectrometry (G.A.R. Johnston, A.C. K. Triffet and J.A. Wunderlich, Anal. Chem., 1968, 40, 1837-1840)
19. Acetylation of nucleosides and acetyl migration (G.A.R. Johnston, Tetrahedron, 1968, 24, 6987-6993)
20. Die hemmende Wirkung von Glycin und verwandten Aminosäuren auf spinale Neurone (D.R. Curtis, L. Hösli and G.A.R. Johnston, Helv. Physiol. Acta, 1968, 26, CR 205-206)
21. Central actions of ibotenic acid and muscimol (G.A.R. Johnston, D.R. Curtis, W.C. de Groat and A.W. Duggan, Biochem. Pharmacol., 1968, 17, 2488-2489)
22. The oxidation of glycine by D-amino acid oxidase in extracts of mammalian central nervous tissue (W.J. de Marchi and G.A.R. Johnston, J. Neurochem., 1969, 16, 355-361)
23. Glycine-producing transaminase activity in extracts of spinal cord (G.A.R. Johnston and M.V. Vitali, Brain Res., 1969, 12, 471-2)
24. Tetanus toxin and amino acid levels in cat spinal cord (G.A.R. Johnston, W.D. de Groat and D.R. Curtis, J. Neurochem., 1969, 16, 797-800)
25. Glycine, strychnine, picrotoxin and spinal inhibition (D.R. Curtis, A.W. Duggan and G.A.R. Johnston, Brain Res., 1969, 14, 759-62)
26. Glycine:2-oxoglutarate transaminase in rat cerebral cortex (G.A.R. Johnston and M.V. Vitali, Brain Res., 1969, 15, 201-208)
27. Amino acid transmitters (D.R. Curtis and G.A.R. Johnston, Handbook of Neurochemistry, edited by A. Lajtha, vol. 4, Plenum Pres, New York, 1970, 115-134)
28. Gas chromatographic estimations of compounds derived from acetylcholine (G.A.R. Johnston, Helen J. Lloyd and Wilhelmina J. de Marchi, J. Chromatog., 1970, 47, 482-485)
29. Strychnine, glycine and vertebrate postsynaptic inhibition (D.R. Curtis and G.A.R. Johnston, Nature, 1970, 225, 1258-1259)
30. Regional and subcellular distribution studies on glycine:2-oxo-glutarate transaminase activity in cat spinal cord (G.A.R. Johnston, M. Valeria Vitali and Heather M. Alexander, Brain Res., 1970, 20, 361-367)
31. GABA, bicuculline and central inhibition (D.R. Curtis, A.W. Duggan, D. Felix and G.A.R. Johnston, Nature, 1970, 226, 1222-1224)
32. The inactivation of extracellularly administered amino acids in the feline spinal cord (D.R. Curtis, A.W. Duggan and G.A.R. Johnston, Exp. Brain Res., 1970, 10, 447-462)
33. Glutamate and related amino-acids in cat, dog and rat spinal roots (A.W. Duggan and G.A.R. Johnston, Comp. Gen. Pharmacol., 1970, 1, 127-128)
34. Glutamate and related amino acids in cat spinal roots, dorsal root ganglia and peripheral nerves (A.W. Duggan and G.A.R. Johnston, J. Neurochem., 1970, 17, 1205-1208)
35. Bicuculline and central GABA receptors (D.R. Curtis, A.W. Duggan, D. Felix and G.A.R. Johnston, Nature, 1970, 228, 676-677)
36. L-Dopa and pyridoxal 5'-phosphate: tetrahydroisoquinoline formation (G.A.R. Johnston, Lancet, 1971, i, 1068)
37. L-Dopa and vitamin B6 (G.A.R. Johnston, Lancet, 1971,ii, 220-221)
38. Bicuculline, an antagonist of GABA and synaptic inhibition in the spinal cord (D.R. Curtis, A.W. Duggan, D. Felix and G.A.R. Johnston, Brain Res., 1971, 32, 69-96)
39. The specificity of strychnine as a central glycine antagonist (D.R. Curtis, A.W. Duggan and G.A.R. Johnston, Exp. Brain Res., 1971, 12, 547-565)
40. Antagonism between bicuculline and GABA in the cat brain (D.R. Curtis, A.W. Duggan, D. Felix, G.A.R. Johnston and H. McLennan, Brain Res., 1971, 33, 57-73)
41. Muscimol and the uptake of gamma-aminobutyric acid by rat brain slices (G.A.R. Johnston, Psychopharmacol., 1971, 22, 230-233)
42. 4-Aminotetrolic acid: a new conformationally-restricted analogue of gamma-aminobutyric acid (P.M. Beart, D.R. Curtis and G.A.R. Johnston, Nature New Biology, 1971, 234, 80-81)
43. GABA uptake in rat central nervous system: comparison of uptake in slices and homogenates and the effects of some inhibitors (L.L. Iversen and G.A.R. Johnston, J. Neurochem., 1971, 18, 1939-1950)
44. Glycine uptake in rat central nervous system slices and homogenates: evidence for different uptake systems in spinal cord and cerebral cortex (G.A.R. Johnston and L.L. Iversen, J. Neurochem., 1971, 18, 1951-1961)
45. The effects of bicuculline, metrazol, picrotoxin and strychnine on the release of 3H-GABA by rat brain slices (G.A.R. Johnston and J.F. Mitchell, J. Neurochem., 1971, 18, 2441-2446)
46. Bicuculline and GABA-metabolising enzymes (P.M. Beart and G.A.R. Johnston, Brain Res., 1972, 38, 226-7)
47. gamma-Aminobutyrylcholine and central inhibition (G.A.R. Johnston and D.R. Curtis, J. Pharm. Pharmacol., 1972, 24, 251-2)
48. Excitation of mammalian central neurones by acidic amino acids (D.R. Curtis, A.W. Duggan, D. Felix, G.A.R. Johnston, A.K. Tebecis and J.C. Watkins, Brain Res., 1972, 41, 283-301)
49. Acetylenic analogues of gamma-aminobutyric acid (P.M. Beart and G.A.R. Johnston, Aust. J. Chem., 1972, 25, 1359-1361)
50. Convulsive action of penicillin (D.R. Curtis, C.J.A. Game, G.A.R. Johnston, R.M. McCulloch and R.M. Maclachlan, Brain Res., 1972, 43, 242-245)
51. Inhibition of GABA transaminase activity by 4-aminotetrolic acid (P.M. Beart, M.L. Uhr and G.A.R. Johnston, J. Neurochem., 1972, 19, 1849-54)
52. Competitive inhibition of GABA uptake in rat brain slices by some GABA analogues of restricted conformation (P.M. Beart, G.A.R. Johnston and M.L. Uhr, J. Neurochem., 1972, 19, 1855-1861)
53. The structural specificity of the high affinity uptake of L-glutamate and L-aspartate by rat brain slices (V.J. Balcar and G.A.R. Johnston, J. Neurochem., 1972, 19, 2657-2666)
54. Glutamate uptake by brain slices and its relation to depolarisation of neurones by acidic amino acids (V.J. Balcar and G.A.R. Johnston, J. Neurobiol., 1972, 3, 295-301)
55. Bicuculline methochloride as a GABA antagonist (G.A.R. Johnston, P.M. Beart, D.R. Curtis, C.J.A. Game, R.M. McCulloch and R.M. Maclachlan, Nature New Biol., 1972, 240, 219-220)
56. Convulsions induced in 10-day-old rats by intraperitoneal injection of monosodium glutamate and related amino acids (G.A.R. Johnston, Biochem. Pharmacol., 1973, 22, 137-140)
57. Antagonism of neuronal excitation by 1-hydroxy-3-aminopyrrolidone-2 (D.R. Curtis, G.A.R. Johnston, C.J.A. Game and R.M. McCulloch, Brain Res., 1973, 49, 467-470)
58. Transamination of analogues of gamma-aminobutyric acid by extracts of rat brain mitochondria (P.M. Beart and G.A.R. Johnston, Brain Res., 49, 459-462)
59. GABA uptake in rat brain slices: inhibition by GABA analogues and by various drugs (P.M. Beart and G.A.R. Johnston, J. Neurochem., 1973, 20, 319-324)
60. High affinity uptake of transmitters: studies on the uptake of L-aspartate, GABA, L-glutamate and glycine in cat spinal cord (V.J. Balcar and G.A.R. Johnston, J. Neurochem., 1973, 20, 529-539)
61. Serine hydroxymethyltransferase in the central nervous system: regional and subcellular distribution studies (L.P. Davies and G.A.R. Johnston, Brain Res., 1973, 54, 149-156)
62. Molecular orbital and proton magnetic resonance studies of bicuculline (P.R. Andrews and G.A.R. Johnston, Nature New Biology, 1973, 243, 29-30)
63. High affinity uptake of cyclic AMP in rat brain slices (G.A.R. Johnston and V.J. Balcar, Brain Res., 1973, 59, 451-453)
64. Central actions of shikimin and tutin (D.R. Curtis, J. Davies, C.J.A. Game, G.A.R. Johnston and R.M. McCulloch, Brain Res., 1973, 63, 419-423)
65. Configuration of bicuculline, a GABA antagonist (G.A.R. Johnston and D.R. Curtis, Nature New Biology, 1973, 246, 190)
66. Postnatal changes in the high affinity uptake of glycine and GABA in the rat central nervous system (G.A.R. Johnston and L.P. Davies, J. Neurochem., 1974, 22, 101-105)
67. Postnatal changes in the levels of glycine and the activities of serine hydroxymethyltransferase and glycine:2-oxoglutarate aminotransferase in the rat central nervous system (L.P. Davies and G.A.R. Johnston, J. Neurochem., 1974, 22, 107-112)
68. Allylglycine, an inhibitor of the uptake of L-leucine and L-proline in rat brain slices (V.J. Balcar and G.A.R. Johnston, Biochem. Pharmacol., 1974, 23, 821-827)
69. Spinal interneurone excitation by conformationally restricted analogues of L-glutamic acid (G.A.R. Johnston, D.R. Curtis, J. Davies and R.M. McCulloch, Nature, 1974, 248, 804-805)
70. Amino-oxyacetic acid: a relatively non-specific inhibitor of uptake of amino acids and amines by brain and spinal cord (G.A.R. Johnston and V.J. Balcar, J. Neurochem., 1974, 22, 609-610)
71. Central effects of beta-(p-chlorophenyl)-gamma-aminobutyric acid (D.R. Curtis, C.J.A. Game, G.A.R. Johnston and R.M. McCulloch, Brain Res., 1974, 70, 493-499)
72. The uptake of GABA into rat spinal roots (J. Davies and G.A.R. Johnston, J. Neurochem., 1974, 22, 931-935)
73. Neurotoxic amino acids (G.A.R. Johnston, in Neuropoisons, Their Pathophysiological Actions, Volume 2 - Poisons of Plant Origin edited by L.L. Simpson and D.R. Curtis, Plenum Press, New York, 1974, pp. 179-205)
74. Convulsant alkaloids (D.R. Curtis and G.A.R. Johnston, in Neuropoisons, Their Pathophysiological Actions, Volume 2 - Poisons of Plant Origin edited by L.L. Simpson and D.R. Curtis, Plenum Press, New York, 1974, pp. 207-248)
75. Amino acid transmitters in the mammalian central nervous system (D.R. Curtis and G.A.R. Johnston, Rev. Physiol., 1974, 69, 97-188)
76. Central actions of bicuculline (D.R. Curtis, G.A.R. Johnston, C.J.A. Game and R.M. McCulloch, J. Neurochem., 1974, 23, 605-606)
77. The differential sensitivity of spinal interneurones and Renshaw cells to kainate and N-methyl-D-aspartate (R.M. McCulloch, G.A.R. Johnston, C.J.A. Game and D.R. Curtis, Exp. Brain Res., 1974, 21, 515-518)
78. Liberation of amino acids during the preparation of brain slices (V.J. Balcar and G.A.R. Johnston, Brain Res., 1975, 83, 173-175)
79. Cis and trans-4-aminocrotonic acid as GABA analogues of restricted conformation (G.A.R. Johnston, D.R. Curtis, P.M. Beart, C.J.A. Game, R.M. McCulloch and B. Twitchin, J. Neurochem., 1975, 24, 157-160)
80. Biochemistry of glycine, taurine, glutamate and aspartate (G.A.R. Johnston, in Handbook of Psychopharmacology edited by L.L. Iversen, S.D. Iversen and S.H. Snyder, for Plenum Press, New York, Volume 4, 1975, pp. 59-81)
81. High affinity uptake of L-glutamine in rat brain slices (V.J. Balcar and G.A.R. Johnston, J. Neurochem., 1975, 24, 875-879)
82. D-aspartate oxidase activity in extracts of mammalian central nervous tissue (L.P. Davies and G.A.R. Johnston, J. Neurochem., 1975, 25, 299-304)
83. Postnatal changes in the potassium-stimulated, calcium dependent release of radioactive GABA and glycine from slices of rat central nervous tissue (L.P. Davies, G.A.R. Johnston and A.L. Stephanson, J. Neurochem., 1975, 25, 387-392)
84. Chemical instability of the GABA antagonist bicuculline under physiological conditions (R.W. Olsen, M. Bann, T. Miller and G.A.R. Johnston, Brain Res., 1975, 98, 383-387)
85. Glutamate and other excitatory amino acids in the mammalian CNS (G.A.R. Johnston, Proc. Sixth Int. Cong. Pharmac., 1975, 2, 81-90)
86. Inhibition of GABA uptake in rat brain slices by nipecotic acid, various isoxazoles and related compounds (P. Krogsgaard-Larsen and G.A.R. Johnston, J. Neurochem., 1975, 25, 797-802)
87. Structure and biological activity of a series of conformationally restricted analogues of GABA (P. Krogsgaard-Larsen, G.A.R. Johnston, D.R. Curtis, C.J.A. Game and R.M. McCulloch, J. Neurochem., 1975, 25, 803-809)
88. Inhibition of acetylcholinesterase by bicuculline and related alkaloids (E. Breuker and G.A.R. Johnston, J. Neurochem., 1975, 25, 903-904)
89. Betel nut constituents as inhibitors of gamma-aminobutyric acid uptake (G.A.R. Johnston, P. Krogsgaard-Larsen and A. Stephanson, Nature, 1975, 258, 627-628)
90. Glycine enzymes and uptake systems (M.L. Uhr and G.A.R. Johnston, in Research Methods in Neurochemistry, New York, Volume 3, 1975, pp. 139-163)
91. Physiologic pharmacology of GABA and its antagonists in the vertebrate nervous system (G.A.R. Johnston, in GABA in Nervous System Function, edited by E. Roberts, T.N. Chase and D.B. Tower, for Raven Press, New York, pages 394-411, 1976)
92. Transport of L-proline by rat brain slices (V.J. Balcar, G.A.R. Johnston and A.L. Stephanson, Brain Res., 1976, 102, 143-151)
93. Inhibitors of the glial uptake of beta-alanine in rat brain slices (G.A.R. Johnston and A.L. Stephanson, Brain Res., 1976, 102, 374-378
94. Uptake and release of nipecotic acid by rat brain slices (G.A.R. Johnston, A.L. Stephanson, and B. Twitchin, J. Neurochem., 1976, 26, 83-87)
95. Inhibition of the uptake of GABA and related amino acids in rat brain slices by the optical isomers of nipecotic acid (G.A.R. Johnston, P. Krogsgaard-Larsen, A.L. Stephanson and B. Twitchin, J. Neurochem., 1976, 26, 1029-1033)
96. Uptake and release of D- and L-aspartate by rat brain slices (L.P. Davies and G.A.R. Johnston, J. Neurochem., 1976, 26, 1007-1015)
97. Glutamate and aspartate as transmitters in the spinal cord (G.A.R. Johnston, Adv. Biochem. Psychopharm., 1976, 15, 175-184)
98. Amino acid inhibitory transmitters in the central nervous system (G.A.R. Johnston, in Chemical Transmission in the Mammalian Central Nervous System, edited by C.H. Hockman and D.L. Bieger, University Park Press, Baltimore, Md., pages 31-81, 1976)
99. X-Ray crystallographic and proton magnetic resonance spectroscopic investigations of nipecotic acid, a potent inhibitor of gamma-aminobutyric acid (GABA) uptake (L. Brehm, P. Krogsgaard-Larsen, G.A.R. Johnston and K. Schaumberg, Acta Chem. Scand. B, 1976, 30, 542-548)
100. The uptake of GABA and beta-alanine in slices of cat and rat CNS tissue: regional differences in susceptibility to inhibitors (D. Lodge, G.A.R. Johnston and A.L. Stephanson, J. Neurochem., 1976, 27, 1569-1570)
101. Central actions of benzodiazepines (D.R. Curtis, D. Lodge, G.A.R. Johnston and S.J. Brand, Brain Res., 1976, 118, 344-347)
102. Stereospecificity of 2,4-diaminobutyric acid (DABA) with respect to inhibition of 4-aminobutyric acid (GABA) uptake and binding (G.A.R. Johnston and B. Twitchin, Brit J. Pharmac., 1977, 59, 218-219)
103. Effects of calcium on the potassium-stimulated release of radioactive beta-alanine and gamma-aminobutyric acid from slices of rat cerebral cortex and spinal cord (G.A.R. Johnston, Brain Res., 1977, 121, 179-181)
104. Effects of gabaculine on the uptake, binding and metabolism of GABA (R.D. Allan, G.A.R. Johnston and B. Twitchin, Neuroscience Letters, 1977, 4, 51-54)
105. Stereospecificity of the inhibition of L-glutamate and L-aspartate high affinity uptake in rat brain slices by threo-3-hydroxyaspartate (V. Balcar, G.A.R. Johnston and B. Twitchin, J. Neurochem., 1977, 28, 1145-1146)
106. Piperazic acid and related compounds as inhibitors of GABA uptake in rat brain slices (G.A.R. Johnston, A.L. Stephanson and B. Twitchin, J. Pharm. Pharmac., 1977, 29, 240-241)
107. A new class of GABA agonist (P. Krogsgaard-Larsen, G.A.R. Johnston, D. Lodge and D.R. Curtis, Nature, 1977, 268, 53-55)
108. Effects of the Areca nut constituents arecaidine and guvacine on the action of GABA in the central nervous system (D. Lodge, G.A.R. Johnston, D.R. Curtis and S.J. Brand, Brain Res., 1977, 136, 513-522)
109. Amino acid receptors (G.A.R. Johnston, in Receptors in Pharmacology edited by J.R. Smythies and R.J. Bradley, Dekker, New York, 1978, pp. 295-333)
110. Neuropharmacology of amino acid inhibitory transmitters (G.A.R. Johnston, Ann. Rev. Pharmacol. Toxicol., 1978, 18, 269-289)
111. Bicuculline-sensitive GABA agonists (G.A.R. Johnston, P. Krogsgaard-Larsen, D. Lodge, and D.R. Curtis in Iontophoresis and Transmitter Mechanisms in the Mammalian Central Nervous System edited by R.W. Ryall and J.S. Kelly, Elsevier, Amsterdam, 1978, pp. 372-374)
112. In vivo correlates of in vitro GABA uptake inhibition in cat CNS (D. Lodge, G.A.R. Johnston and D.R. Curtis, in Iontophoresis and Transmitter Mechanisms in the Mammalian Central Nervous System edited by R.W. Ryall and J.S. Kelly, Elsevier, Amsterdam, 1978, pp. 378-380)
113. Structure-activity studies on the inhibition of GABA binding to rat brain membranes by muscimol and related compounds (P. Krogsgaard-Larsen and G.A.R. Johnston, J. Neurochem., 1978, 30, 1377-1382)
114. Transmitter inactivation processes (G.A.R. Johnston, Proc. Aust. Physiol. Pharmac. Soc., 1978, 9, 94-98)
115. GABA receptors and phospholipids (G.A.R. Johnston and S.M.E. Kennedy, in Amino Acids as Chemical Transmitters, edited by F. Fonnum, Plenum Press, New York, 1978, pp. 507-516)
116. Muscimol uptake, release and binding in rat brain slices (G.A.R. Johnston, S.M.E. Kennedy and D. Lodge, J. Neurochem., 1978, 31, 1519-1523)
117. Does uptake limit the action of GABA agonists in vivo? Experiments with muscimol, isoguvacine and THIP in cat spinal cord (D. Lodge, D.R. Curtis and G.A.R. Johnston, J. Neurochem., 1978, 31, 1525-1528)
118. Action of the neurotoxin kainic acid on high affinity uptake of L-glutamic acid in rat brain slices (G.A.R. Johnston, S.M.E. Kennedy and B. Twitchin, J. Neurochem., 1979, 32, 121-127)
119. Central nervous system receptors for glutamic acid (G.A.R. Johnston, in Glutamic Acid: Advances in Biochemistry and Physiology edited by L.J. Filer, S. Garattini, M.R. Kare, W.A. Reynolds and R.J. Wurtman, Raven Press, New York, 1979, pp. 177-185)
120. Systematic study of GABA analogues of restricted conformation (G.A.R. Johnston, R.D. Allan, S.M.E. Kennedy and B. Twitchin, in GABA-Neurotransmitters, edited by P. Krogsgaard-Larsen, J. Scheel-Kruger and H. Kofod, Munksgaard, Copenhagen, 1979, pp. 149-164)
121. Stereospecific actions of GABA analogues (G.A.R. Johnston, R.D. Allan, P.R. Andrews, S.M.E. Kennedy and B. Twitchin, in Advances in Pharmacology and Therapeutics, Volume 2, Neurotransmitters, edited by P. Simon, Pergamon Press, Oxford, 1979, pp. 11-18)
122. Dihydromuscimol, thiomuscimol and related heterocyclic compounds as GABA analogues (P. Krogsgaard-Larsen, H. Hjeds, D.R. Curtis, D. Lodge and G.A.R. Johnston, J. Neurochem., 1979, 32, 1717-1724)
123. Conformational analysis of muscimol, a GABA agonist (P.R. Andrews and G.A.R. Johnston, J. Theor. Biol., 1979, 79, 263-273)
124. GABA agonists and antagonists (P.R. Andrews and G.A.R. Johnston, Biochem. Pharmac., 1979, 28, 2697-2702)
125. Kainate neurotoxicity and glutamate inactivation (D. Lodge, G.A.R. Johnston, D.R. Curtis and J.C. Bornstein, Neurosci. Letters, 1979, 14, 343-348)
126. Barbiturates and calcium-activated adenosine triphosphatase (M. Willow and G.A.R. Johnston, Neurosci. Letters, 1979, 14, 361-364)
127. Amino acid neurotoxins (G.A.R. Johnston, in Neurotoxins, Fundamental and Clinical Advances, edited by I.W. Chubb and L.B. Geffen, Adelaide University Union Press, Adelaide, 1979, pp. 199-205)
128. Synthesis of analogues of GABA. III. All four stereoisomers of 3-aminocyclopentanecarboxylic acid and a stereochemical correlation with amidinomycin (R.D. Allan, G.A.R. Johnston and B. Twitchin, Aust. J. Chem., 1979, 32, 2517-2521)
129. Potentiation of L-glutamate and L-aspartate excitation of cat spinal neurones by the stereoisomers of threo-3-hydroxy aspartate (G.A.R. Johnston, D. Lodge, J.C. Bornstein and D.R. Curtis, J. Neurochem., 1980, 34, 241-243)
130. In vivo inactivation of quisqualate: studies in cat spinal cord (D. Lodge, D.R. Curtis, G.A.R. Johnston and J.C. Bornstein, Brain Res., 1980, 182, 491-495)
131. The synthesis and activity of cis- and trans-2-(aminomethyl)-cyclopropane carboxylic acid as conformationally restricted analogues of GABA (R.D. Allan, D.R. Curtis, P.M. Headley, G.A.R. Johnston, D. Lodge and B. Twitchin, J. Neurochem., 1980, 34, 651-655)
132. Cyclobutane analogs of GABA (R.D. Allan, D.R. Curtis, P.M. Headley, G.A.R. Johnston, S.M.E. Kennedy, D. Lodge and B. Twitchin, Neurochem. Res., 1980, 5, 43-50)
133. Baclofen: stereoselective inhibition of excitant amino acid release (G.A.R. Johnston, M.H. Hailstone and C.G. Freeman, J. Pharm. Pharmac., 1980, 32, 230-231)
134. Selective antagonist activity of 5-aminohex-2-enedioic acid on amino acid excitation of cat spinal neurones (R.D. Allan, J.C. Bornstein, D.R. Curtis, G.A.R. Johnston and D. Lodge, Neuroscience Lett., 1980, 16, 17-20)
135. The effects of anaesthetic and convulsant barbiturates on the efflux of [3H]D-aspartate from brain minislices (M. Willow, J.C. Bornstein and G.A.R. Johnston, Neuroscience Lett., 1980, 18, 185-190)
136. Enhancement of GABA binding by pentobarbitone (M. Willow and G.A.R. Johnston, Neuroscience Lett., 1980, 18, 323-327)
137. gamma-Aminobutyric acid agonists: an in vitro comparison between depression of spinal synaptic activity and depolarization of spinal root fibres in the rat (R.D. Allan, R.H. Evans and G.A.R. Johnston, Brit. J. Pharmac., 1980, 70, 609-615)
138. Synthesis of analogues of GABA. V. trans and cis isomers of some 4-amino-3-halogenobut-2-enoic acids (R.D. Allan, G.A.R. Johnston and B. Twitchin, Aust. J. Chem., 1980, 33, 1115-1122)
139. Barbiturates and GABA receptors (G.A.R. Johnston and M. Willow, in GABA and Benzodiazepine Receptors, edited by E. Costa, G. DiChiara and G.L. Gessa, Raven Press, New York, 1981, pp. 191-198)
140. Uptake and release of N-methyl-D-aspartate by rat brain slices (J.H. Skerritt and G.A.R. Johnston, J. Neurochem., 1981, 36, 881-885)
141. Enhancement by anaesthetic and convulsant barbiturates of GABA binding to rat brain synaptosomal membranes (M. Willow and G.A.R. Johnston, J. Neurosci., 1981, 1, 364-367)
142. Glutamate uptake and its possible role in neurotransmitter inactivation (G.A.R. Johnston, in Glutamate: Transmitter in the Central Nervous System edited by P.J. Roberts, J. Storm-Mathisen and G.A.R. Johnston, Wiley, London, 1981, pp. 77-87)
143. Direct excitant action of convulsant barbiturates (P.R. Andrews, R.H. Evans, G.A.R. Johnston and M. Willow, Experientia, 1981, 37, 172-174)
144. GABA receptors (G.A.R. Johnston, in The Role of Peptides and Amino Acids as Neurotransmitters, ed. J.B. Lombardini and A.D. Kenny, Alan Liss, New York, 1981, pp. 1-17)
145. Pentobarbitone slows the dissociation of GABA from rat brain synaptosomal binding sites (M. Willow and G.A.R. Johnston, Neuroscience Letters, 1981, 23, 71-74)
146. Increased GABA binding in mouse brain following acute swim stress (J.H. Skerritt, P. Trisdikoon and G.A.R. Johnston, Brain Res., 1981, 215, 398-403)
147. Dual action of pentobarbitone of GABA binding: role of binding site integrity (M. Willow and G.A.R. Johnston, J. Neurochem., 1981, 37, 1291-1294)
148. Phenobarbitone binding sites in rat brain synaptosomal membranes (M. Willow, I.G. Morgan and G.A.R. Johnston, Neurosci. Letters, 1981, 24, 301-306)
149. Glutamate and Huntington's Disease (P.R. Sanberg and G.A.R. Johnston, Med. J. Aust., 1981, 2, 460-465)
150. Synthesis of analogues of GABA. VI. Stereoisomers of cis-3-amino-cyclohexane carboxylic acid (R.D. Allan, G.A.R. Johnston and B. Twitchin, Aust. J. Chem., 1981, 34, 2231-2236)
151. Endogenous inhibitors of GABA receptors: developmental, drug and environmental aspects (G.A.R. Johnston, J.H. Skerritt and M. Willow, in Problems in GABA Research, ed. Y. Okada and E. Roberts, Excerpta Medica, 1982, pp. 293-301)
152. Ethylenediamine as a GABA agonist: enhancement of diazepam binding and interaction with GABA receptors and uptake sites (L.P. Davies, J.W. Hambley and G.A.R. Johnston, Neurosci. Letters, 1982, 29, 57-61)
153. Diazepam enhancement of low affinity GABA binding to rat brain membranes (J.H. Skerritt, M. Willow and G.A.R. Johnston, Neurosci. Letters, 1982, 29, 63-66)
154. GABA and barbiturate receptors (G.A.R. Johnston and M. Willow, Trends Pharmacol. Sci., 1982, 3, 328-330; reprinted in More About Receptors, ed. J.W. Lamble, Elsevier Biomedical Press, Amsterdam, 1982, pp. 111-114)
155. Postnatal development of GABA binding sites and their endogenous inhibitors in rat brain (J.H. Skerritt and G.A.R. Johnston, Devel. Neurosci., 1982, 5, 189-197)
156. A purinergic component in the anticonvulsant action of carbamazepine? (J.H. Skerritt, L.P. Davies and G.A.R. Johnston, Eur. J. Pharmacol., 1982, 82, 195-197)
157. In vitro and in vivo effects of pentobarbitone sodium (M. Willow, M.J. Peet, G.A.R. Johnston and D.R. Curtis, J. Pharm. Pharmac., 1982, 34, 686)
158. Contrasting regulation by GABA of the displacement of benzodiazepine antagonist binding by benzodiazepine agonists and purines (J.H. Skerritt, L.P. Davies, S. Chen Chow and G.A.R. Johnston, Neuroscience Letters, 1982, 32, 169-174)
159. Differences in the interactions between GABA and benzodiazepine binding sites (J.H. Skerritt, S. Chen Chow and G.A.R. Johnston, Neuroscience Letters, 1982, 33, 173-178)
160. Purines interact with "central" but not "peripheral" benzodiazepine binding sites (J.H. Skerritt, S. Chen Chow, G.A.R. Johnston and L.P. Davies, Neuroscience Letters, 1982, 34, 63-68)
161. Contrasting effects of a convulsant (CHEB) and an anticonvulsant barbiturate (phenobarbitone) on amino acid release from rat brain slices (J.H. Skerritt, M. Willow and G.A.R. Johnston, Brain Res., 1983, 258, 271-276)
162. Synthetic analogs for the study of GABA as a neurotransmitter (R.D. Allan and G.A.R. Johnston, Med. Res. Rev., 1983, 3, 91-118)
163. Synthesis of analogues of GABA. IX. 5-(Aminomethyl)-3-hydroxy-2(5H)-furanone (R.D. Allan, G.A.R. Johnston, R. Kazlauskas and H. Tran, Aust. J. Chem., 1983, 36, 977-981)
164. Enhancement of excitant amino acid release from rat brain slices by the convulsant 3-mercaptopropionic acid (J.H. Skerritt and G.A.R. Johnston, Brain Res., 1983, 258, 165-169)
165. Pharmacology of barbiturates: electrophysiological and neurochemical studies (M. Willow and G.A.R. Johnston, Int. Rev. Neurobiol., 1983, 24, 15-49)
166. Inhibition of amino acid transmitter release from rat brain slices by phenytoin and related anticonvulsants (J.H. Skerritt and G.A.R. Johnston, Clin. Exp. Pharmacol. Physiol., 1983, 10, 527-533)
167. Relationships between ethylenediamine and GABA transport in rat brain slices (L.P. Davies, C.A. Drew, S. Chen Chow, J.H. Skerritt and G.A.R. Johnston, Neurochem. Int., 1983, 5, 57-64)
168. Modulation of GABA binding to rat brain membranes by alkyl beta-carboline-3- carboxylate esters (J.H. Skerritt, G.A.R. Johnston and C. Braestrup, Eur. J. Pharmac., 1983, 86, 299-302)
169. Differences in uptake kinetics of cis-3-aminocyclohexane carboxylic acid into neurons and astrocytes in primary cultures (O.L. Larsson, G.A.R. Johnston and A. Schousboe, Brain Res., 1983, 260, 279-285)
170. Excitotoxins (G.A.R. Johnston, in Molecular Pathology of Nerve and Muscle, ed. A. Kidman, Humana Press, New Jersey, pp. 195-202, 1983)
171. Enhancement of GABA binding by benzodiazepines and related anxiolytics (J.H. Skerritt and G.A.R. Johnston, Eur. J. Pharmac., 1983, 89, 193-198)
172. Interactions of carbamazepine with benzodiazepine receptors (J.H. Skerritt, G.A.R. Johnston and S. Chen Chow, J. Pharm. Pharmac., 1983, 35, 464-465)
173. Pyrazolo[3,4-d]pyrimidines, a new class of adenosine antagonists (L.P. Davies, D.J. Brown, S. Chen Chow and G.A.R. Johnston, Neuroscience Letters, 1983, 41, 189-193)
174. Synthesis of analogues of gamma-aminobutyric acid. Part 11. Unsaturated and saturated tetronic acid derivatives (R.D. Allan, G.A.R. Johnston, R. Kazlauskas and H.W. Tran, J. Chem. Soc. Perkin 1, 1983, 2983-2985)
175. Regulation of GABA receptors by barbiturates and by related sedative-hypnotic and anticonvulsant drugs (G.A.R. Johnston, in The GABA Receptors, edited by S.J. Enna, Humana Press, New Jersey, pp. 107-128, 1983)
176. Diazepam stimulates the binding of GABA and muscimol but not THIP to rat brain membranes (J.H. Skerritt and G.A.R. Johnston, Neurosci. Lett., 1983, 38, 315-320)
177. Actions of pentobarbitone and derivatives with modified 5-butyl substituents on GABA and diazepam binding to rat brain synaptosomal membranes (J.H. Skerritt, G.A.R. Johnston, T. Katsikas, J. Tabar, G.M. Nicholson and P.R. Andrews, Neurochem. Res., 1983, 8, 1337-1350)
178. Interactions of some anaesthetic, convulsant and anticonvulsant drugs at GABA-benzodiazepine receptor-ionophore complexes in rat brain synaptosomal membranes (J.H. Skerritt and G.A.R. Johnston, Neurochem. Res., 1983, 8, 1351-1362)
179. Interactions of the anticonvulsant, carbamazepine, with adenosine receptors. (1) Neurochemical studies (J.H. Skerritt, L.P. Davies and G.A.R. Johnston, Epilepsia, 1983, 24, 634-641)
180. Interactions of the anticonvulsant, carbamazepine, with adenosine receptors. (2) Pharmacological studies (J.H. Skerritt, G.A.R. Johnston and S. Chen Chow, Epilepsia, 1983, 24, 643-650)
181. GABA Receptors (G.A.R. Johnston, R.D. Allan and J.H. Skerritt, Handbook of Neurochemistry, 1984, 6, 213-237)
182. GABARINS and the nexus between GABA and benzodiazepine receptors (G.A.R. Johnston and J.H. Skerritt, in Actions and Interactions of GABA and Benzodiazepines, ed. N.G. Bowery, Raven Press, New York, pp 179-189, 1984)
183. Resolution of the stereoisomers of baclofen by high performance liquid chromatography (R.P. Weatherby, R.D. Allan and G.A.R. Johnston, J. Neurosci. Methods, 1984, 10, 23-28)
184. Interaction of purines and related compounds with photoaffinity-labelled benzodiazepine receptors in rat brain membranes (L.P. Davies, S. Chen Chow and G.A.R. Johnston, Europ. J. Pharmac., 1984, 97, 325-329)
185. Pyrazolo[3,4-d]pyrimidines as adenosine antagonists (L.P. Davies, S. Chen Chow, J.H. Skerritt, D.J. Brown and G.A.R. Johnston, Life Sci., 1984, 34, 2117-2128)
186. GABA agonists (G.A.R. Johnston and R.D. Allan, Neuropharmacology, 1984, 23, 831-832)
187. GABA receptors and related binding sites (G.A.R. Johnston, R.D. Allan, A.D. Benton, S. Chen Chow, C.A. Drew, B.P. Hiern, G. Holan, R. Kazlauskas, H. Rzezniczak and R.P. Weatherby, in Proceedings of 9th International Congress of Pharmacology, London, 1984, 3, 179-183)
188. Alterations in a hypothalamic GABA system in the spontaneously hypertensive rat (J.W. Hambley, G.A.R. Johnston and J. Shaw, Neurochem. International, 1984, 6, 813-821)
189. Bicuculline-insensitive GABA receptors: studies on the binding of (-)-baclofen to rat cerebellar membranes (C.A. Drew, G.A.R. Johnston and R.P. Weatherby, Neurosci. Letters, 1984, 52, 317-321)
190. Modulation of excitant amino acid release by convulsant and anticonvulsant drugs (J.H. Skerritt and G.A.R. Johnston, in Neurotransmitters, Seizures and Epilepsy II, ed. R.G Fariello, P.L. Morselli, K.G. Lloyd, L.F. Quesney and J. Engel, Raven Press, New York, 1984, 215-224)
191. Differential modulation of GABA receptors by caprolactam derivatives with CNS depressant or convulsant activity (J.H. Skerritt, G.A.R. Johnston, S. Chen Chow, R.L. Macdonald, R.H. Prager and A.D. Ward, Brain Res., 1985, 331, 225-233)
192. Acute effects of lead at central synapses in vitro (I. Spence, C. Drew, G.A.R. Johnston and D. Lodge, Brain Res., 1985, 333, 103-109)
193. Strychnine-like action of the convulsant barbiturate, CHEB (G.M. Nicholson, I. Spence and G.A.R. Johnston, Neuropharmacology, 1985, 24, 465-471)
194. Effects of a depressant/convulsant pair of glutarimides on neuronal activity in the isolated spinal cord of the immature rat (G.M. Nicholson, I. Spence and G.A.R. Johnston, Neuropharmacology, 1985, 24, 461-464)
195. Multidisciplinary studies in the design of new insecticides (G. Holan, W.M.P. Johnson, D.F. O'Keefe, G.L. Quint, K. Rihs, T.H. Spurling, R. Walser, C.T. Virgona, C. Frelin, M. Lazdunski, G.A.R. Johnston and S. Chen Chow, in Recent Advances in the Chemistry of Insect Control, edited by N.F. Janes, Royal Society of Chemistry, London, 1985, pp. 114-132)
196. Effect of ketamine on amino acid evoked release of acetylcholine from rat cerebral cortex in vitro (D. Lodge and G.A.R. Johnston, Neuroscience Letters, 1985, 56, 371-375)
197. Uptake of gamma-aminobutryic acid by human blood platelets: comparison with CNS uptake (J.W. Hambley and G.A.R. Johnston, Life Sciences, 1985, 36, 2053-2062)
198. Synthesis of analogues of GABA. XIII. An alternative route to (Z)-4-aminocrotonic acid (R.D. Allan, G.A.R. Johnston and R. Kazlauskas, Aust. J. Chem., 1985, 38, 1647-1650)
199. Synthesis of analogues of GABA. XIV. Synthesis and activity of unsaturated derivatives of 5-aminopentanoic acid (delta-aminovaleric acid) (R.D. Allan, H.W. Dickenson, G.A.R. Johnston, R. Kazlauskas and H.W. Tran, Aust. J. Chem., 1985, 38, 1651-1656)
200. Neurochemical studies on the inhibitory transmitter GABA (G.A.R. Johnston, Chem. Aust., 1986, 53, 47-48)
201. Multiplicity of GABA receptors (G.A.R. Johnston, in Benzodiazepine/GABA Receptors and Chloride Channels: Structural and Functional Properties, ed. R.W. Olsen and J.C. Venter, Alan Liss, New York, 1986, pp. 57-71)
202. Isothiouronium compounds as gamma-aminobutyric acid agonists (R.D. Allan, H.W, Dickenson, B.P. Hiern, G.A.R. Johnston and R. Kazlauskas, Brit. J. Pharmac., 1986, 88, 379-387)
203. The uptake of GABA and glycine by synaptosomes from post mortem human brain (J.A. Hardy, A. Barton, E. Lofdahl, S.C. Cheetham, G.A.R. Johnston and P.R. Dodd, J. Neurochem., 1986, 47, 460-467)
204. Adenosine receptors in post mortem human cerebral cortex and the effect of carbamazepine, (P.R. Dodd, W.E.J. Watson and G.A.R. Johnston,Clin. exp. Pharmacol. Physiol., 1986, 13, 711-722)
205. Optimization of freezing, storage and thawing conditions for the preparation of metabolically active synaptosomes from frozen rat and human brain (P.R. Dodd, J.A. Hardy, F.B. Baig, A.M. Kidd, E.D. Bird, W.E.J. Watson and G.A.R. Johnston, Neurochem. Pathol., 1986, 4, 177-198)
206. Blood pressure development in SHR & WKY rats; effects of neonatal MSG treatment and evidence for transient hypertension in WKY rats (J.W. Hambley, G.A.R. Johnston and L.J. Rogers, Neuroscience Letters, 1987, 83, 190-194)
207. gamma-Aminobutyric acid receptor ionophore complexes: differential effects of deltamethrin, DDT and some novel insecticides in a rat brain membrane preparation (S.C.R. Lummis, S. Chen Chow, G. Holan and G.A.R. Johnston, J. Neurochem., 1987, 48, 689-694)
208. Effects of chronic ethanol inhalation on the enhancement of benzodiazepine binding to mouse brain membranes by GABA (D.J. de Vries, G.A.R. Johnston, L.C. Ward, P.A. Wilce and B.C. Shanley, Neurochemistry International, 1987, 10, 231-235)
209. Brain GABA receptor binding is normal in rats with thioacetamide-induced hepatic encephalopathy despite elevated plasma GABA-like activity ( J.E. Maddison, P.R. Dodd, G.A.R. Johnston and G.C. Farrell, Gastroenterology, 1987, 93, 1062-1068)
210. Plasma GABA, GABA-like activity and the brain GABA-benzodiazepine receptor complex in rats with chronic hepatic encephalopathy (J.E. Maddison, P.R. Dodd, M. Morrison, G.A.R. Johnston and G.C. Farrell, Hepatology, 1987, 7, 621-628)
211. Calcium dependence of baclofen- and GABA-induced depression of responses to transmural stimulation in the guinea-pig isolated ileum (J. Ong, D.I.B. Kerr and G.A.R. Johnston, Eur. J. Pharmac., 1987, 134, 369-372)
212. Differing actions of beta-phenyl-GABA and baclofen in the guinea-pig isolated ileum (J. Ong, D.I.B. Kerr and G.A.R. Johnston, Neuroscience Letters, 1987, 77, 109-112)
213. GABA receptors and their modulation (G.A.R. Johnston, in Integration and Control of Metabolic Processes: Pure and Applied Aspects, O.L. Kon (Editor), ICSU Press, Cambridge, 1987, pp. 103-117)
214. Ontogeny of GABAergic systems in the brain (V.J. Balcar and G.A.R. Johnston, in GABA as a Trophic Agent in Neuronal Development, D.A. Redburn and A. Schousboe (eds.) Alan R. Liss, New York, pp 57-77, 1987)
215. Reduced adenosine deaminase activity in the CNS of spontaneously hypertensive rats (L.P. Davies, J.W. Hambley and G.A.R. Johnston, Neurochemistry International, 1987, 10, 533-536)
216. Effect of chronic lead treatment on the development of neuromuscular connections in the rat (I. Spence, H. Chen, C. Drew and G.A.R. Johnston, NeuroToxicology, 1987, 8, 403-410)
217. A comparison of high affinity synaptosomal uptake of D-aspartate in rat and human brain (R.F. Cowburn, P.R. Dodd, J.A. Hardy and G.A.R. Johnston, Neurochemistry International, 1987, 10, 339-346)
218. Effect of ethanol on the GABA-benzodiazepine receptor in brain (D.J. de Vries, L.C. Ward, P.A. Wilce, G.A.R. Johnston and B.C. Shanley, Alcohol & Alcoholism, 1987, Suppl. 1, 663-667)
219. Cortisol: a potent biphasic modulator at GABA-A-receptor-complexes in the guinea-pig isolated ileum (J. Ong, D.I.B. Kerr and G.A.R. Johnston, Neuroscience Letters, 1987, 82, 101-106)
220. Pregnenolone and its sulphate modulate GABA-A-receptor-mediated contractile responses in the guinea-pig isolated ileum (J. Ong, D.I.B. Kerr and G.A.R. Johnston, Europ. J. Pharmac., 1987, 142, 461-464)
221. Stress, steroids and GABA receptors (G.A.R. Johnston, D.I.B. Kerr and J. Ong, Pharmacology - Proc. Xth Int. Cong. Pharmacol., M.J. Rand and C. Raper, editors, Elsevier, Amsterdam, 1987, pp. 121-124)
222. Differing actions of convulsant and nonconvulsant barbiturates: an electrophysiological study in the isolated spinal cord of the rat (G.M. Nicholson, I. Spence and G.A.R. Johnston, Neuropharmacology, 1988, 27, 459-465)
223. High affinity uptake of cAMP in rat brain: inhibition by coronary vasodilators dilazep and hexobendine (V.J. Balcar, A.L. Gundlach and G.A.R. Johnston, Neurochemistry International, 1988, 12, 19-24)
224. Towards new and improved antiepileptic drugs (G.A.R. Johnston, Aust. Prescriber, 1988, 11, 9-11)
225. Plasma GABA concentrations and cerebro-cortical GABA receptor binding and function in dogs with congenital portosystemic encephalopathy (J.E. Maddison, P.R. Dodd, M. Morrison, G.C. Farrell and G.A.R. Johnston, in Advances in ammonia metabolism and hepatic encephalopathy, edited by P.B. Soeters, J.H.P. Wilson, A.J. Meijer and E. Holm, for Elsevier, Amsterdam, 1988, pp 265-274)
226. GABA-B receptor antagonist and GABA-A receptor agonist properties of a d-aminovaleric acid derivative, Z-5-aminopent-2-enoic acid (H.W. Dickenson, R.D. Allan, J. Ong and G.A.R. Johnston, Neuroscience Letters, 1988, 86, 351-355)
227. Purine enzyme inhibition fails to alter benzodiazepine receptor binding in brain (A.L. Gundlach and G.A.R. Johnston, Neurochemistry International, 1988, 12, 533-537)
228. Alfaxalone potentiates and mimics GABA-induced contractile responses in the guinea-pig isolated ileum (J. Ong, D.I.B. Kerr and G.A.R. Johnston, Brit. J. Pharmac., 1988, 98, 33-38)
229. 2-Hydroxy-saclofen: an improved antagonist at central and peripheral GABA-B receptors (D.I.B. Kerr, J. Ong, G.A.R. Johnston, J. Abbenante and R.H. Prager, Neuroscience Letters, 1988, 92, 92-96)
230. Non-dopaminergic actions of quinpirole hydrochloride (LY 171555), a selective D2-agonist, in the guinea-pig isolated ileum (J. Ong, D.M. Jackson, G.A.R. Johnston and D.I.B. Kerr, J. Pharm. Pharmacol., 1988, 40, 746-747)
231. Depolarizing action of convulsant barbiturates on isolated rat dorsal root ganglion cells (G.M. Nicholson, I. Spence and G.A.R. Johnston, Neuroscience Letters, 1988, 93, 330-335)
232. Deficit of spinal cord glycine/strychnine receptors in inherited myoclonus of Poll Hereford calves (A.L. Gundlach, P.R. Dodd, C.S.G. Grabara, W.E.J. Watson, G.A.R. Johnston, P.A.W. Harper, J.A. Dennis and P.J. Healy, Science, 1988, 241, 1807-1810)
233. Involvement of adenosine in synaptic depression induced by a brief period of hypoxia in isolated spinal cord of neonatal rat (H.G.E. Lloyd, I. Spence and G.A.R. Johnston, Brain Research, 1988, 462, 391-395)
234. Necropsy study of GABA/benzodiazepine receptor binding sites in brain tissue from chronic alcoholic patients (J.J, Kril, P.R. Dodd, A.L. Gundlach, N. Davies, W.E.J. Watson, G.A.R. Johnston and C.G. Harper, Clin. Exp. Neurol., 1988, 25, 135-141)
235. The effects of lead salts on the uptake, release and binding of gamma-aminobutyric acid: the importance of buffer composition (C.A. Drew, I. Spence and G.A.R. Johnston, J. Neurochem., 1989, 52, 433-440)
236. GABA-B-receptor-mediated actions of baclofen in rat isolated neocortical slices preparations: antagonism by phosphono-analogues of GABA (D.I.B. Kerr, J. Ong, G.A.R. Johnston and R.H. Prager, Brain Res., 1989, 480, 312-316)
237. Polyclonal antibodies to the glycine receptor antagonist strychnine (P.P. Phelan, J.P. Fry, I.L. Martin and G.A.R. Johnston, J. Neurochem., 1989, 52, 1481-1486)
238. Uptake of gamma-aminobutyric and L-glutamic acids by synaptosomes from postmortem human cerebral cortex: multiple sites, sodium dependence and effects of tissue preparation (P.R. Dodd, W.E.J. Watson, M.L. Morrison, G.A.R. Johnston, E.D. Bird, R.F. Cowburn and J.A. Hardy, Brain Res., 1989, 490, 320-331)
239. GABA enzymes and transport systems (G.A.R. Johnston and V.J. Balcar, in GABA: basic research to clinical implications, N.G. Bowery and G. Nistico, ed., Pythagora Press, Rome, pp. 1-23, 1989)
240. Cortical dihydropyridine binding sites are unaltered in human alcoholic brain (J.J. Kril, A.L. Gundlach, P.R. Dodd, G.A.R. Johnston and C.G. Harper, Ann. Neurol., 1989, 26, 395-397
241. Plasma GABA-like factor in hepatic encephalopathy may be taurine (J.E. Maddison, D.K. Leong, P.R. Dodd and G.A.R. Johnston, in Hepatic Encephalopathy: Pathophysiology and Treatment, R.F. Butterworth, ed., Raven Press, New York, pp. 329-338, 1989)
242. Antagonism at GABA-B receptors by saclofen and related sulphonic analogues of baclofen and GABA (D.I.B. Kerr, J. Ong, G.A.R. Johnston, J. Abbenante and R.H. Prager, Neuroscience Letters, 1989, 107, 239-244)
243. Neurochemical studies on quinolone antibiotics: effects on glutamate, GABA and adenosine systems in mammalian CNS (P.R. Dodd, L.P. Davies, W.E.J. Watson, B. Nielsen, J.A. Dyer, L.S. Wong and G.A.R. Johnston, Pharmacol. & Toxicol., 1989, 64, 404-411)
244. Benzofuran analogues of baclofen: a new class of central and peripheral GABA-B-receptor antagonists (D.I.B. Kerr, J. Ong, G.A.R. Johnston, P. Berthelot, M. Debaert and C. Vaccher, Europ. J. Pharmacol., 1989, 164, 361-364)
245. Ontogeny of high affinity uptake of GABA studied in "minislices" (tissue prisms) of rat cerebral cortex (V.J. Balcar and G.A.R. Johnston, Developmental Brain Research, 1989, 49, 295-299)
246. Plasma GABA-like activity in rats with hepatic encephalopathy is due to GABA and taurine (J.E. Maddison, D.K. Leong, P.R. Dodd and G.A.R. Johnston, Hepatology, 1990, 11, 105-110)
247. A new synthesis, resolution and in vitro activities of (R)- and (S)-beta-phenyl-GABA (R.D. Allan, M.C. Bates, C.A. Drew, R.K. Duke, T.W. Hambley, G.A.R. Johnston, K.N. Mewett and I. Spence, Tetrahedron, 1990, 46, 2511-2524)
248. Stress and cortisol modulation of GABA receptors (D.I.B. Kerr, J. Ong and G.A.R. Johnston, Stress & Anxiety, 1990, 13, 209-213)
249. Differing actions of baclofen and 3-amino-propylphosphinic acid in rat neocortical slices (J. Ong, D.I.B. Kerr, G.A.R. Johnston and R.G. Hall, Neuroscience Letters, 1990, 109, 169-173)
250. (+)-Hydrastine, a potent competitive antagonist at mammalian GABA-A receptors (J.H. Huang and G.A.R. Johnston, Brit. J. Pharmac., 1990, 99, 727-730)
251. Neonatal stress and long-term modulation of GABA receptors in rat brain (S.W. Bolden, J.W. Hambley, G.A.R. Johnston and L.J. Rogers, Neuroscience Letters, 1990, 111, 258-262)
252. Effect of chronic exposure to lead on GABA binding in developing rat brain (C.A. Drew, I. Spence and G.A.R. Johnston, Neurochemistry International, 1990, 17, 43-51)
253. Inhibition of baclofen binding to rat cerebellar membranes by phaclofen, saclofen, 3-aminopropylphosphinic acid and related GABA-A receptor antagonists (C.A. Drew, G.A.R. Johnston, D.I.B. Kerr and J. Ong, Neuroscience Letters, 1990, 113, 107-110)
254. Effects of potassium channel blockers on baclofen-induced suppression of paroxysmal discharges in rat neo-cortical slices (J. Ong, D.I.B. Kerr and G.A.R. Johnston, Neuroscience Letters, 1990, 112, 216-222)
255. Receptor alterations associated with spinal motoneuron degeneration in bovine Akabane disease (A.L. Gundlach, C.S.G. Grabara, G.A.R. Johnston and P.A.W. Harper, Annals of Neurology, 1990, 27, 513-519)
256. Increased GABA receptor function in cerebral cortex of calves with an inherited deficit of spinal glycine/strychnine receptors (S.C.R, Lummis, A.L. Gundlach, G.A.R. Johnston, P.A.W. Harper and P.R. Dodd, J. Neurochem., 1990, 55, 421-426)
257. Binding to rat brain membranes of (+)-trans-(1S,3S)-3-aminocyclopentane-1-carboxylic acid, (+)-TACP, a selective GABA-A receptor agonist (H.W. Dickenson, R.K. Duke, V.J. Balcar, R.D. Allan and G.A.R. Johnston, Molecular Neuropharmacology, 1990, 1, 1-6)
258. Calcium-dependent actions of the convulsant barbiturate, CHEB, on transmitter release at the rat neuromuscular junction (G.M. Nicholson, I. Spence and G.A.R. Johnston, General Pharmacology, 1990, 21, 741-746)
259. Synthesis and activity of a potent N-methyl-D-aspartic acid agonist, trans--1-aminocyclobutane-1,3-dicarboxylic acid, and related phosphonic and carboxylic acids (R.D. Allan, J.R. Hanrahan, T.W. Hambley, G.A.R. Johnston, K.N. Mewett and A.D. Mitrovic, J. Med. Chem., 1990, 33, 2905-2915)
260. 3-Aminopropanephosphinic acid is a potent agonist at peripheral and central presynaptic GABA-B receptors (J. Ong, N.L. Harrison, R.G. Hall, J.L.Barker, G.A.R. Johnston and D.I.B. Kerr, Brain Research, 1990, 526, 138-142)
261. Cortisone, a potent GABA-A antagonist in the guinea-pig isolated ileum (J. Ong, D.I.B. Kerr, H.R. Capper and G.A.R. Johnston, J. Pharm. Pharmacol., 1990, 42, 662-664)
262. Anxiety, steroids and GABA receptors (G.A.R. Johnston, in Anxiety, N. McNaughton and G. Andrews, eds, University of Otago Press, Dunedin, 1990, pp. 201-212)
263. Anxiety chemistry (G.A.R. Johnston, Chemistry in Australia, 1990, 57, 334-337; reprinted in Australian Chemistry Resource Book, 1991, 10, 15-21)
264. Inhibition of high affinity L-glutamic acid uptake into rat cortical synaptosomes by the conformationally restricted analogue of glutamic acid, cis-1-aminocyclobutane-1,3-dicarboxylic acid (E.J. Fletcher, K.N. Mewett, C.A. Drew, R.D. Allan and G.A.R. Johnston, Neuroscience Letters, 1991, 121, 133-135)
265. ZAPA, a substrate for the neuronal high affinity GABA uptake system in rat brain slices (R.D. Allan, H.W. Dickenson, R.K. Duke and G.A.R. Johnston, Neurochemistry International, 1991, 18, 63-67)
266. Regional heterogeneity of L-glutamate and L-aspartate high affinity uptake systems in the rat CNS (E.J. Fletcher and G.A.R. Johnston, J. Neurochem., 1991, 57, 911-914)
267. Alterations in cortical [3H]-kainate and [3H]-AMPA binding in a spontaneous animal model of chronic hepatic encephalopathy (J.E. Maddison, W.E.J. Watson, P.R. Dodd and G.A.R. Johnston, J. Neurochem., 1991, 56, 1881-1888)
268. Cerebellar [3H]-kainate and [3H]-AMPA binding in dogs with congenital portosystemic encephalopathy (J.E. Maddison, W.E.J. Watson and G.A.R. Johnston, Neurochemistry International, 1991, 19, 511-515)
269. GABA-A antagonists (G.A.R. Johnston, Seminars in the Neurosciences, 1991, 3, 205-210)
270. Gamma-aminobutyric acid-modulated benzodiazepine binding sites in bacteria (S.C.R. Lummis, G. Nicoletti, G.A.R. Johnston and G. Holan, Life Sciences, 1991, 49, 1079-1086)
271. Glutamate and brain function (G.A.R. Johnston, Food Australia, 1991, 43, S10-S11)
272. The synthesis of 1,8-disubstituted 10,11-dihydrodibenz-[b,f]oxepin-10-ones. Analogues of anaesthetic steroids (P.M. Burden, H.R. Capper, R.D. Allan and G.A.R. Johnston, J. Chem. Soc. Perkin Trans. 1, 1991, 3291-3294)
273. The interaction of a Huntington's disease factor with receptors for the neurotoxin kainic acid (P.R. Dodd, W.E.J. Watson, M.M. Morrison, G.A.R. Johnston, A.I. Smith, A. Ruwoldt and R.S. Walls, Metabolic Brain Disease, 1991, 6, 213-214)
274. Bicuculline- and baclofen-insensitive GABA binding to rat cerebellar membranes (C.A. Drew and G.A.R. Johnston, J. Neurochem., 1992, 58, 1087-1092)
275. Routine screening and quantitation of urinary corticosteroids using bench top GC mass selective detector (B.K. Yap, G.A.R. Johnston and R. Kazlauskas, J. Chromatog., 1992, 57, 183-190)
276. GABA-A agonists as targets for drug development (G.A.R. Johnston, Clin. Exp. Pharmac. Physiol., 1992, 19, 73-78)
277. Molecular modelling of N-methyl-D-aspartate (NMDA) receptor agonists and antagonists (H.R. Capper, K.N. Mewett, R.D. Allan and G.A.R. Johnston, Molecular Neuropharmacology, 1992, 2, 83-87)
278. Stress-induced changes in GABA-A binding sites (G.A.R. Johnston and M.K. Akinci, Molecular Neuropharmacology, 1992, 2, 151-154)
279. Excitatory amino acid and purine release from hippocampal synaptosomes: an in vitro model for studying presynaptic mechanisms involved in ischaemia (H.G.E. Lloyd, M. Morrison and G.A.R. Johnston, Molecular Neuropharmacology, 2, 211-214)
280. Cerebro-cortical [3H]CNQX binding in dogs with congenital portosystemic encephalopathy and control dogs (J.E. Maddison, W.E.J. Watson and Johnston, G.A.R., Molecular Neuropharmacology, 2, 237-240)
281. CNQX binding to non-NMDA glutamate receptors in canine cerebro-cortical crude synaptosomal membranes: pharmacological characterisation and comparison of binding parameters in dogs with congenital portosystemic encephalopathy and control dogs (J.E. Maddison, W.E.J. Watson and Johnston, G.A.R., Metabolic Brain Disease, 1992, 7, 35-44)
282. The glutamate and GABA neurotransmitter systems in the acute phase of maple syrup urine disease and citrullinaemia encephalopathies in newborn calves (P.R. Dodd, S.H. Williams, A.L. Gundlach, P.A.W. Harper, P.J. Healy, J.A. Dennis and G.A.R. Johnston, J. Neurochem., 1992, 59, 582-590)
283. Kava pyrones and resin: studies on GABA-A, GABA-B and benzodiazepine binding sites in rodent brain (L.P. Davies, C.A. Drew, P. Duffield, G.A.R. Johnston and D.D. Jamieson, Pharmacology & Toxicology, 1992, 71, 120-126)
284. Sex differences in the effects of acute swim stress on binding to GABA-A receptors in mouse brain (M.K. Akinci and G.A.R. Johnston, J. Neurochem., 1993, 60, 2212-2216)
285. A Huntington Disease factor which inhibits [3H]kainate binding also blocks synaptosomal amino acid transport in rat brain (D.K. Leong, P.R. Dodd and G.A.R. Johnston, Neurochem. Internat., 1993, 23, 131-138)
286. R-(-)-beta-Phenyl-GABA is a full agonist at GABA-B receptors in brain slices but a partial agonist in the ileum (J. Ong, D.I.B. Kerr, D.J. Doolette, R.K. Duke, K.N. Mewett, R.D. Allan and G.A.R. Johnston, Eur. J. Pharmacol., 1993, 233, 169-172)
287. Application of neural networks to quantitative structure-activity relationships of benzodiazepine/GABA-A receptor binding compounds (D.J. Maddalena and G.A.R. Johnston, Proceedings of the fourth Australian Conference on Neural Networks, 1993,228-231)
288. Glutamate and imprinting memory: the role of glutamate receptors in the encoding of imprinting memory (A.N. Johnston, L.J. Rogers and G.A.R. Johnston, Behavioural Brain Res., 1993, 54, 137-143)
289. The preparation of tritiated E- and Z-4-aminobut-2-enoic acids, conformationally restricted analogues of the inhibitory neurotransmitter 4-aminobutanoic acid (GABA) (R.K. Duke, R.D. Allan, C.A. Drew, G.A.R. Johnston, K.N. Mewett, M.A. Long and C. Than, Journal of Labelled Compounds and Radiopharmaceuticals, 1993, 33, 527-540)
290. The synthesis and resolution of tritiated 4-amino-3-phenylbutanoic acid ([3H]R- and [3H]S-beta-phenylGABA) (R.K. Duke, R.D. Allan, C.A. Drew, G.A.R. Johnston, K.N. Mewett, M.A. Long and C. Than, Journal of Labelled Compounds and Radiopharmaceuticals, 1993, 33, 767-775)
291. Sex differences in acute swim stress induced changes in the binding of MK-801 to the NMDA subclass of glutamate receptors in mouse forebrain (M.K. Akinci and G.A.R. Johnston, Journal of Neurochemistry, 1993, 61, 2290-2293)
292. Brain chemistry: sex differences (G.A.R. Johnston, in Horizons of Chemistry, ed. P. Pockley, Centre for Science Communication, University of Technology, Sydney, 1993, pp. 12-16)
293. Professional societies and their support for codes of ethics (G.A.R. Johnston, in Ethics and the Practising Scientist, ed. R.J. Hunter, Centre for the Human Aspects of Science and Technology, University of Sydney, 1993, pp. 26-34)
294. Regional differences in the inhibition of L-glutamate and L-aspartate sodium-dependent high affinity uptake systems in rat CNS synaptosomes by L-trans-pyrrolidine-2,4-dicarboxylate, threo-3-hydroxy-D-aspartate and D-aspartate (A.D. Mitrovic and G.A.R. Johnston, Neurochemistry International, 1994, 24, 583-588)
295. GABA-C receptors (G.A.R. Johnston, Progress in Brain Research, 1994, 100, 61-65)
296. Sex differences in acute swim stress induced changes in the binding of AMPA (alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid) and kainate to glutamate receptors in mouse forebrain (M.K. Akinci and G.A.R. Johnston, Neurochemistry International, 1994, 25, 169-174)
297. GABA receptors - as complex as ABC? (G.A.R. Johnston, Clinical and Experimental Pharmacology and Physiology, 1994, 21, 521-526)
298. Application of neural networks to quantitative structure-activity relationships of benzodiazepine/GABA-A receptor binding compounds (D.J. Maddalena and G.A.R. Johnston, in The Challenge of Neuropharmacology, a Tribute to the Memory of Willy Haefely, edited by H. Möhler & M. Da Prada, Editiones Roche, Basel, 1994, pages 136-139)
299. GABA-B antagonists: resolution, absolute stereochemistry and pharmacology of (R)- and (S)-phaclofen (K Frydenvang, P Krogsgaard-Larsen, J.J. Hansen, A. MItrovic, H. Tran, C.A. Drew and G.A.R. Johnston, Chirality, 1994, 6, 583-589)
300. GABA receptor pharmacology (G.A.R. Johnston, in Pharmacological Sciences: Perspectives for Research and Therapy in the late 1990s, edited by A.C. Cuello and B. Collier, Birkhäuser, Basel, 1995, pp. 11-15) [PDF]
301. Prediction of receptor properties and binding affinity of ligands to benzodiazepine/GABA-A receptors using artificial neural networks (D.J. Maddalena and G.A.R. Johnston, Journal of Medicinal Chemistry, 1995, 38, 715-724) [PDF]
302. Idiospermuline, a trimeric pyrroldinoindoline alkaloid from the seed of Idiospermum australiense (R.K. Duke, R.D. Allan, C.C. Duke, T.W. Hambley, G.A.R. Johnston, K.N. Mewett and A.D. Mitrovic, J. Nat. Products Lloydia, 1995, 58, 1200-1208) [PDF]
303. L-Glutamate and g-aminobutyric acid uptake in synaptosomes from the cerebral cortex of dogs with congenital chronic hepatic encephalopathy (J.E. Maddison, W.E.J. Watson and G.A.R. Johnston, Metabolic Brain Disease, 1995, 10, 135-141) [PDF]
304. Synaptosomal and brain slice cerebrocortical 3H-L-glutamate uptake in a rat model of hepatic encephalopathy (J.E. Maddison, W.E.J. Watson and G.A.R. Johnston, Neurochemistry International, 1996, 28, 89-93) [PDF]
305. GABA-A receptor pharmacology (G.A.R. Johnston, Pharmacology & Therapeutics, 1996, 69, 173-198) [PDF]
306. Differential sensitivity during development of GABA-mediated synaptic transmission to a neuroactive steroid in rat hippocampus and cerebellum (E.J. Cooper, G.A.R. Johnston and F.A. Edwards, in GABA : Receptors, Transporters and Metabolism, edited by C. Tanaka and N.G. Bowery, Birkhäuser, Basel, 1996, pp. 195-200) [PDF]
307. Receptor binding sites and uptake activities mediating GABA neurotransmission in chronic alcoholics with Wernicke encephalopathy (P.R. Dodd, J.J. Kril, G.J. Thomas, W.E.J. Watson, G.A.R. Johnston and C.G. Harper, Brain Res., 1996, 710, 215-228). [PDF]
308. Comparison of binding parameters of s1 and s2 binding sites in rat and guinea pig brain membranes: Novel subtype-selective trishomocubanes (VH Nguyen, M. Kassiou, GAR Johnston and MJ Christie, European Journal of Pharmacology, 1996, 311, 233-240) [PDF]
309. Profiling of urinary testosterone and luteinizing hormone in exercise-stressed male athletes using gas chromatography-mass spectrometry and enzyme immunoassay techniques (B.K. Yap, R. Kazlauskas, K. Elghazi, G.A.R. Johnston and RP Weatherby, J. Chromat. B. Biomed. Appl., 1996, 687, 117-125) [PDF]
310. Small molecules as drugs (G.A.R. Johnston, Chemistry in Australia, 1996, 64, 212-213) [PDF]
311. Synthesis of unsaturated analogues of glutamic acid by amination of trianions from unsaturated dicarboxylic acids with chloramine (RD Allan, RK Duke, TW Hambley, GAR Johnston, KN Mewett, N. Quickert and HW Tran, Aust. J. Chem., 1996, 49, 785-791) [PDF]
312. GABA-C receptors: relatively simple transmitter-gated ion channels? (GAR Johnston, Trends in Pharmacological Sciences, 1996, 17, 319-323) [PDF]
313. Theoretical studies on the free-radical bromination of methyl-pyridazines in the synthesis of novel heterocyclic analogues of neurotransmitters (JR Greenwood, G. Vaccarella, HR Capper, KN Mewett, RD Allan and GAR Johnston, Journal of Molecular Structure (Theochem), 1996, 368, 235-243) [PDF]
314. Molecular biology, pharmacology and physiology of GABA-C receptors (G.A.R. Johnston, in The GABA Receptors, second edition, S.J. Enna and N.G. Bowery, eds, Humana Press, New Jersey, 1997, pp. 297-323) [PDF]
315. Structural analogues of ZAPA as GABA-A Agonists (RD Allan, HW Dickenson, GAR Johnston, R Kazlauskas and KN Mewett, Neurochemistry International, 1997, 30, 583-591) [PDF]
316. Stimulation of [3H]GABA and [3H]b-alanine release from rat brain slices by cis-4-aminocrotonic acid (M Chebib and GAR Johnston, Journal of Neurochemistry, 1997, 68, 786-794) [PDF]
317. Sex differences in the effects of gonadectomy and acute swim stress on GABA-A receptor binding in mouse forebrain membranes (MK Akinci and GAR Johnston, Neurochemistry International, 1997, 31, 1-10) [PDF]
318. Contrasting modes of action of methylglutamate derivatives on the excitatory amino acid transporters, EAAT1 and EAAT2 (RJ Vandenberg, AD Mitrovic, M Chebib, VJ Balcar and GAR Johnston, Mol. Pharmacol., 1997, 51, 809-815) [PDF]
319. Tautomerism of hydroxy-pyridazines: the N-oxides (JR Greenwood, HR Capper, RD Allan and GAR Johnston, Journal of Molecular Structure (Theochem), 1997, 419, 97-111) [PDF]
320. Unsaturated phosphinic analogues of GABA as GABA-C receptor antagonists (M Chebib, RJ Vandenberg, W Froestl and GAR Johnston, European Journal of Pharmacology, 1997, 329, 223-239) [PDF]
321. Cerebral chemistry (GAR Johnston, Chemistry in Australia, 1997, 64(5), 34-36; reprinted in the Australian Chemistry Resource Book, 1997, 16, 67-72) [PDF]
322. Analogues of g-aminobutryic acid (GABA) and trans-4-aminocrotonic acid (TACA) substituted in the 2 position as GABA-C receptor antagonists (M. Chebib, RJ Vandenberg and GAR Johnston, British Journal of Pharmacology, 1997, 122, 1551-1560) [PDF]
323. Serine-O-sulfate transport by the human glutamate transporter EAAT2 (RJ Vandenberg, AD Mitrovic and GAR Johnston, British Journal of Pharmacology, 1998, 123, 1593-1600) [PDF]
324. Molecular basis for differential inhibition of glutamate transporter subtypes by zinc ions (RJ Vandenberg, AD Mitrovic and GAR Johnston, Molecular Pharmacology, 1998, 54, 189-196) [PDF]
325. Identification of functional domains of the human glutamate transporters EAAT1 and EAAT2 (AD Mitrovic, SG Amara, GAR Johnston and RJ Vandenberg, Journal of Biological Chemistry, 1998, 273, 14698-14706) [PDF]
326. The Tautomerism of pyridazinediones (JR Greenwood, HR Capper, RD Allan and GAR Johnston, Internet Journal of Chemistry, 1998, 1, article 21; http://www.ijc.com/articles/1998v1/21/) [PDF]
327. Propylene glycol elicits anxiolytic-like responses to the elevated plus maze in male mice (HQ Lin, PM Burden and GAR Johnston, J. Pharm. Pharmac., 1998, 50, 1127-1131) [PDF]
328. Resolution and conformational analysis of diastereoisomers of cis- and trans-2-(aminomethyl)-1-carboxycyclopropanes (RK Duke, RD Allan, M Chebib, JR Greenwood and GAR Johnston, Tetrahedron Asymmetry, 1998, 9, 2533-2548) [PDF]
329. Heterocycles as bioisosteres for the w-carboxylate moiety of glutamate in AMPA receptor agonists: A review and theoretical study (JR Greenwood, G Vaccarella, HR Capper, RD Allan, and GAR Johnston, Internet Journal of Chemistry, 1998, 1, article 38; [PDF]
330. GABA-C receptor antagonists differentiate between human r1 and r2 receptors expressed in Xenopus oocytes (M Chebib, KN Mewett and GAR Johnston, European Journal of Pharmacology, 1998, 357, 227-234) [PDF]
331. The Synthesis of 2-Cyclohexylideneoctahydro-4,7-methano-1H-indenes. Non-Steroidal Analogues of Steroidal GABA-A Receptor Modulators (PM Burden, RD Allan, T Hambley and GAR. Johnston, Journal of the Chemical Society, Perkin Transactions 1, 1998, 3163-3169) [PDF]
332. Influence of the oestrous cycle on L-glutamate and L-aspartate transport in rat brain synaptosomes (AD Mitrovic, JE Maddison and GAR Johnston, Neurochemistry International, 1999, 34, 101-108) [PDF]
333. Medicinal chemistry and molecular pharmacology of GABA receptors and glutamate transporters: complementary structure-activity relationships (GAR Johnston, M Chebib, RK Duke, KN Mewett, AD Mitrovic and RJ Vandenberg, Drug Development Research, 1999, 46, 255-260) [PDF]
334. The anxiogenic-like and anxiolytic-like effects of MDMA on mice in the elevated plus maze: a comparison with amphetamine (HG Lin, PM Burden, MJ Christie and GAR Johnston, Pharmacology Biochemistry and Behavior, 1999, 62, 403-408) [PDF]
335. Stereoselective interaction of thiopentone enantiomers with the GABA-A receptor (DJ Cordato, M Chebib, LE Mather, GK Herkes and GAR Johnston, British Journal of Pharmacology, 1999, 128, 77-82) [PDF]
336. The ABC of GABA receptors: A brief review (M Chebib and GAR Johnston, Clinical and Experimental Pharmacology and Physiology, 1999, 26, 937-940) [PDF]
337. Aminomethyl-2,6-difluorophenols as a novel class of increased lipophilicity GABA-C receptor antagonists (Chebib M, Johnston GAR, Mattsson JP, Rydström K, Nilsson K, Qiu K, Stevenson SH and Silverman RB, Bioorganic & Medicinal Chemistry Letters, 1999, 9, 3093-3098) [PDF]
338. Effects of a naturally occurring neurosteroid on GABA-A IPSCs during development in rat hippocampal or cerebellar slices (EJ Cooper, GAR Johnston and FA Edwards, Journal of Physiology, 1999, 521.2, 437-449) [PDF]
339. Ionotropic GABA receptors: ligand gated ion channels (GAR Johnston, M Chebib and RK Duke, in Control and Diseases of Sodium Dependent Transport Proteins and Ion Channels, Edited by Y Suketa, E Carafoli, M Lazdunski, K Mikoshiba, Y Okada and EM Wright, Elsevier Science, Amsterdam, The Netherlands, pp. 369-372, 2000) [PDF]
340. GABA Chemistry: Analogs of GABA as therapeutic and investigational agents (GAR Johnston, in GABA in the Nervous System: The View at Fifty Years, Edited by David L. Martin and Richard W. Olsen, Lippincott Williams & Wilkins Publishers, Philadelphia, PA, USA, 65-80, 2000) [PDF]
341. GABA-activated ligand gated ion channels: medicinal chemistry and molecular biology (Chebib M and Johnston GAR, Journal of Medicinal Chemistry, 2000, 43, 1427-1447) [PDF]
342. The medicinal chemistry-molecular biology interface: recombinant receptors in the search for new drugs (Johnston GAR, in Technology & Health, Proceedings of the 13th Convocation of the Council of Academies of Engineering and Technological Sciences, ISBN 2-7430-0386-3, Paris, France, 2000, pp 72-74) [PDF]
343. (+)- and (-)-cis-2-Aminomethylcyclopropanecarboxylic acid show opposite pharmacology at recombinant r1 and r2 GABAA receptors (Duke RK, Chebib M, Balcar VJ, Allan RD, Mewett KN and Johnston GAR, Journal of Neurochemistry, 2000, 75, 2602-2610) [PDF]
344. Chiral derivatives of 2-cyclohexylideneperhydro-4,7-methanoindenes, a novel class of nonsteroidal androgen receptor ligand. Synthesis, X-ray analysis and biological activity (Burden PM, Ai TH, Lin HQ, Akinci M, Costandi M, **Hambley TM and Johnston GAR, Journal of Medicinal Chemistry, 2000, 43, 4629-4635) [PDF]
345. Effect of a series of novel sulfonylthioureas on glucose tolerance in the obese fa/fa Zucker rat (Farrar NS, Chambers NJ, Carlsson AR, **Denyer G and Johnston GAR Clinical and Experimental Pharmacology and Physiology, 2001, 28, 386-391) [PDF]
346. 6-Methylflavone (Hall BJ, Hanrahan JR, Johnston GAR, **Hambley TW and Hibbs DE '6-Methylflavone" Acta Crystallographia, 2001, E57, o592-o593) (http://scripts.iucr.org/cgi-bin/paper?tk6019) [PDF]
347. An improved, versatile synthesis of the GABA-C antagonists (1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid (TPMPA) and piperidin-4-yl)methylphosphinic acid (P4MPA) (Hanrahan JR, Mewett KN, Chebib M, Burden PM and Johnston GAR, J. Chem. Soc., Perkin Trans. 1, 2001, 19, 2389 -2392) [PDF]
348. The effects of cyclopentane and cyclopentene analogues of GABA at recombinant GABA-C receptors (M Chebib, RK Duke, RD Allan and GAR Johnston, European Journal of Pharmacology, 2001, 430, 185-192) [PDF]
349. trans-4-Amino-2-methylbut-2-enoic acid (2-MeTACA) and (±)-trans-2-aminomethylcyclopropanecarboxylic acid ((±)-TAMP) can differentiate rat rho-3 from human rho-1 and rho-2 recombinant GABA-C receptors (J Vien, RK Duke, KN Mewett, GAR Johnston, R. Shingai and M Chebib, British Journal of Pharmacology, 2002, 135, 883-890) [PDF]
350. Medicinal chemistry and molecular pharmacology of GABA-C receptors (Johnston GAR, Current Topics in Medicinal Chemistry, 2002, 2, 903-913) [PDF]
351.Ginkgo biloba - food for the brain (Duke RK, Chebib M, Duke CC, Johnston GAR and Roufogalis BD, New Zealand Pharmacy, 2002, 22(5), 27-33) [PDF]
352. Natural and synthetic substances related to human health (IUPAC Technical Report) (*Topliss JG, *Clark AM, *Ernst E., *Hufford C, Johnston GAR , *Rimoldi JM and *Weimann BJ, Pure and Applied Chemistry, 2002, 74, 1957-1985) [PDF]
353. Phosphinic, phosphonic and seleninic acid bioisosteres of isonipecotic acid as novel and selective GABA-C receptor antagonists (Krehan D, Frølund B, Krogsgaard-Larsen, P, Kehler J, Johnston GAR and Chebib M Neurochemistry International, 2003, 42, 561-565) [PDF]
354. Bilobalide, a sesquiterpene trilactone from Ginkgo biloba, is an antagonist at recombinant a1b2g2L GABA-A receptors (Huang SH, Duke RK, Chebib M, *Sasaki K, *Wada K and Johnston GAR ' European Journal of Pharmacology, 2003, 464, 1-8) [PDF]
355. Dietary chemicals and brain function (GAR Johnston, Journal and Proceedings, Royal Society of New South Wales, 2003, 135, 57-71) [PDF]
356. Convulsant actions of calycanthine (M Chebib, RK Duke, M Connor, KN Mewett and GAR Johnston, Toxicology and Applied Pharmacology, 2003, 190, 58-64) [PDF]
357. Semisynthetic preparation of amentoflavone: a negative modulator at GABA-A receptors (JR Hanrahan, M Chebib, NM Davucheron, BJ Hall and GAR Johnston, Bioorganic & Medicinal Chemistry Letters, 2003, 13, 2281-2284) [PDF]
358. GABA-C receptors as drug targets (GAR Johnston, M Chebib, JR Hanrahan and KN Mewett, Current Drug Targets - CNS & Neurological Disorders, 2003, 2, 260-268) [PDF]
359. Aza-THIP and related analogues of THIP as GABA-C antagonists (D Krehan, B Frølund, B Ebert, P Krogsgaard-Larsen, GAR Johnston and M Chebib, Bioorganic and Medicinal Chemistry, 2003, 11, 4891-4896) [PDF]
360. Mutations of the 2' proline in the M2 domain of the human GABA-C rho1 subunit alter agonist responses (JE Carland, AM Moore, JR Hanrahan, KN Mewett, RK Duke, GAR Johnston and M Chebib, Neuropharmacology, 2004, 46, 770-781 [PDF]
361. Flumazenil-independent positive modulation of GABA action by 6-methylflavone at human recombinant alpha1, beta2, gamma2L and alpha1, beta2 GABA-A receptors (Hall BJ, Chebib M, Hanrahan JR and Johnston GAR, European J. Pharmacology, 2004, 491,1-8) [PDF]
362. Flavonoids: some of the wisdom of sage? (Johnston GAR and *Beart PM, British Journal of Pharmacology, 2004, 142, 809-810) [PDF]
363. Synthesis and resolution of 2-methyl analogues of GABA (Duke, RK, Chebib M, Hibbs DE, Mewett, KN and Johnston GAR, Tetrahedron Asymmetry, 2004, 15, 1745-1751) [PDF]
364. GABA transporters GAT-1 and GAT-3 in the human dorsolateral prefrontal cortex in schizophrenia (Schleimer SB, Hinton T, Dixon G and Johnston GAR, Neuropsychobiology, 2004, 50, 226-230) [PDF]
365. Ginkgolides, diterpene trilactones of Ginkgo biloba, as antagonists at recombinant alpha1, beta2, gamma2L GABA-A receptors (Huang SH , Duke RK, Chebib M, Sasaki K, Wada K and Johnston GAR, European Journal of Pharmacology, 2004, 494, 131-138) [PDF]
366. Ionotropic GABA receptors as therapeutic targets for memory and sleep disorders (Chebib M, Hanrahan JR, Mewett KN, Duke RK and Johnston GAR, Annual Reports in Medicinal Chemistry, 2004, 39, 13-23) [PDF]
367. The dietary flavonoids apigenin and (-)-epigallocatechin gallate enhance the positive modulation by diazepam of the activation by GABA of recombinant GABA-A receptors ( Campbell EL, Chebib M and Johnston GAR, Biochemical Pharmacology, 2004, 68, 1631-1638) [PDF]
368. Charged residues at the 2' position of human GABA-C rho1 receptors invert ion selectivity and influence open state probability (JE Carland, AJ Moorhouse, PH Barry, GAR Johnston and M Chebib, Journal of Biological Chemistry, 2004, 279, 54153-54160) [PDF]
369. Novel oral drug administration in an animal model of chronic neuroleptic therapy (SB Schleimer, GAR Johnston and JM Henderson, Journal of Neuroscience Methods, 2005, 146, 159-164 [PDF]
370. GABA-A receptor channel pharmacology (Johnston GAR, Current Pharmaceutical Design, 2005, 11, 1867-1885) [PDF]
371. Opposing roles for GABA-A and GABA-C receptors in short-term memory formation in young chicks (ME Gibbs and GAR Johnston, Neuroscience, 2005, 131, 567-576) [PDF]
372. (+) and (-)-Borneol: efficacious positive modulators of GABA action at human recombinant alpha1beta2gamma2L GABA-A receptors (RE Granger, EL Campbell and GAR Johnston, Biochemical Pharmacology, 2005, 69, 1101-1111) [PDF]
373. 6-Methylflavanone, a more efficacious positive allosteric modulator of gamma-aminobutyric acid (GABA) action at human recombinant alpha2beta2gamma2L than at alpha1beta2gamma2L and alpha1beta2 GABA-A receptors expressed in Xenopus oocytes (BJ Hall, M Chebib, JR Hanrahan and GAR Johnston, European Journal of Pharmacology, 2005, 512, 97-104) [PDF]
374. Enantiomers of cis-constrained and flexible 2-substituted GABA analogues exert opposite effects at recombinant GABA-C receptors (Crittenden DL, Park, A, Qiu J, Silverman RB, Duke RK, Johnston GAR, Jordan MJT and Chebib M Bioorganic and Medicinal Chemistry, 2006, 14, 447-455) [PDF]
375. Mixed antagonistic effects of bilobalide at rho1 GABA-C receptors (SH Huang, RK Duke, M Chebib, K. Sasaki, K Wada and GAR Johnston, Neuroscience, 2006, 137, 607-617) [PDF]
376. Modulation of ionotropic GABA receptors by natural products of plant origin (GAR Johnston, JR Hanrahan,M Chebib, RK Duke and KN Mewett, Advances in Pharmacology, 2006, 54, 285-316) [PDF]
377. Central nervous system depressant action of flavonoid glycosides (SP Fernandez, C Wasowski, LM Loscalzo, RE Granger, GAR Johnston, AC Paladini and M Marder, European Journal of Pharmacology, 2006, 539, 168-176) [PDF]
378. Diastereoselective synthesis of (±)-(3-aminocyclopentanyl)alkylphosphinic acids, conformationally restricted analogues of GABA (JR Hanrahan, KN Mewett, M Chebib, S Matos, CT Eliopoulos, C Crean, RJ Kumar, P Burden, and GAR Johnston., Organic & Biomolecular Chemistry, 2006, 4, 2642 - 2649) [PDF]
379. (3-Aminocyclopentyl)methylphosphinic acids: Novel GABA-C receptor antagonists.(M Chebib, JR Hanrahan, RJ Kumar, KN Mewett, G Morriss, S Wooller and GAR Johnston, Neuropharmacology, 2007, 52, 779-787 [PDF]
380. The effects of antipsychotic drugs on GABA-A receptor binding depend on period of drug treatment and binding site examined (Skilbeck KJ, O'Reilly JN, Johnston GAR and Hinton T, Schizophrenia Research, 2007, 90, 76-80) [PDF]
381. Enantioselective actions of 4-amino-3-hydroxybutanoic acid and (3-amino-2-hydroxypropyl)methylphosphinic acid at recombinant GABA-C receptors (T Hinton, M. Chebib and GAR Johnston, Bioorganic & Medicinal Chemistry Letters, 2008, 18, 402-404) [PDF]
382. Anxiolytic and hypnotic drugs acting on ionotropic GABA receptors (T Hinton and GAR Johnston, Encyclopedia of Neuroscience, edited by M Binder, N Hirokawa, U Windhorst, and MC Hirsch, Springer-Verlag, accepted 15.8.07)
383. Herbal products and ionotropic GABA receptors (GAR Johnston, M Chebib, RK Duke, SP Fernandez, JR Hanrahan, T Hinton and KN Mewett, New Encyclopedia of Neuroscience, edited by L Squire, Elsevier, accepted 29.8.07)
384. Antipsychotic drug administration differentially affects [3H]muscimol and [3H]flunitrazepam GABA-A receptor binding sites (KJ Skilbeck, JN O'Reilly, GAR Johnston and T Hinton, Progress in Neuro-Psychopharmacology & Biological Psychiatry, 2008, 32, 492-498) [PDF]
385. Relative impact of residues at the intracellular and extracellular ends of the human GABA-C rho1 receptor M2 domain on picrotoxinin activity (JE Carland, GAR Johnston and M Chebib, European Journal of Pharmacology, 2008, 580, 27-35) [PDF]
386. Sex-differences and stress: effects on regional high and low affinity [3H]GABA binding (KJ Skilbeck, T Hinton and GAR Johnston, Neurochemistry International, 2008, 52, 1212-1219) [PDF]
387. A molecular basis for agonist and antagonist actions at GABA-C receptors (H Abdel-Halim, JR Hanrahan, DE Hibbs, GAR Johnston and M Chebib, Chemical Biology and Drug Design, 2008, 71, 306-327) [PDF]
388. Novel gamma-aminobutyric acid rho1 receptor antagonists; Synthesis, pharmacological activity and structure activity relationships (RJ Kumar, M Chebib, DE Hibbs, H-L Kim, GAR Johnston, NK Salam and JR Hanrahan, Journal of Medicinal Chemistry, 2008, 51, 3825-3840) [PDF]
389. Flavan-3-ol derivatives are positive modulators of GABA-A receptors with higher efficacy for the alpha2 subtype and anxiolytic action in mice (Fernandez SP, Mewett KN, Hanrahan JR, Chebib M, Johnston GAR, Neuropharmacology, accepted 1.7.08)
390. The role of GABA-A receptors in schizophrenia (T Hinton and GAR Johnston, Cell Science Reviews, 2008, 5, 180-194) [PDF]